Atlas Trials

A Phase II Study of AK146D1 Mono or Combined With AK112 in Advanced Urothelial Carcinoma

Clinical trial NCT07636772 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07636772
Sponsor
Akeso
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Urothelial Carcinoma (UC)
Start date
2026-06-22
Primary completion
2028-08-24
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.